Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Flaherty

Showing results (41-50 of 242) with videos related to

Pageof 25
Sort By:
Pediatric Research|March 28, 2025
Enteral feeding in pediatric patients with bronchiolitis requiring non-invasive support via nasal interfaceKelsey Finnegan, Julia Smalley, Barbara Gallagher, et al.
Behavioural Brain Research|November 2, 2020
Chronic but not acute pharmacological activation of SERCA induces behavioral and neurochemical effects in male and female miceAikaterini Britzolaki, Claire C Cronin, Patrick R Flaherty, et al.
European Heart Journal. Case Reports|March 4, 2020
The use of serial cardiac <sup>18</sup>F-fluorodeoxyglucose- positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and reviewCooper B Kersey, Kathleen R Flaherty, Isaac L Goldenthal, et al.
The European Respiratory Journal|May 19, 2018
What's in a name? That which we call IPF, by any other name would act the sameAthol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
The European Respiratory Journal|June 28, 2018
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosisKevin R Flaherty, Martin Kolb, Carlo Vancheri, et al.
Pulmonary Therapy|February 7, 2020
Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access ProgramLisa Lancaster, Lake Morrison, Alexander Auais, et al.
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Timing of lung transplantation for patients with fibrotic lung diseasesK R Flaherty, E S White, S E Gay, et al.
Journal of Thoracic Imaging|November 18, 2006
Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolutionAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
Academic Pediatrics|March 12, 2019
Screening for Access to Firearms by Pediatric Trainees in High-Risk PatientsCaitlin Naureckas Li, Chana A Sacks, Kyle A McGregor, et al.
Immunotherapy Advances|November 29, 2023
Efficacy of PD-1 checkpoint inhibitor therapy in melanoma and beyond: are peripheral T cell phenotypes the key?Katie R Flaherty, Stephanie Kucykowicz, Johannes Schroth, et al.
Pageof 25

Showing results (41-50 of 242) with videos related to

Sort By:
Pageof 25
Pediatric Research|March 28, 2025
Enteral feeding in pediatric patients with bronchiolitis requiring non-invasive support via nasal interfaceKelsey Finnegan, Julia Smalley, Barbara Gallagher, et al.
Behavioural Brain Research|November 2, 2020
Chronic but not acute pharmacological activation of SERCA induces behavioral and neurochemical effects in male and female miceAikaterini Britzolaki, Claire C Cronin, Patrick R Flaherty, et al.
European Heart Journal. Case Reports|March 4, 2020
The use of serial cardiac <sup>18</sup>F-fluorodeoxyglucose- positron emission tomography imaging to diagnose, monitor, and tailor treatment of cardiac sarcoidosis patients with arrhythmias: a case series and reviewCooper B Kersey, Kathleen R Flaherty, Isaac L Goldenthal, et al.
The European Respiratory Journal|May 19, 2018
What's in a name? That which we call IPF, by any other name would act the sameAthol U Wells, Kevin K Brown, Kevin R Flaherty, et al.
The European Respiratory Journal|June 28, 2018
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosisKevin R Flaherty, Martin Kolb, Carlo Vancheri, et al.
Pulmonary Therapy|February 7, 2020
Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access ProgramLisa Lancaster, Lake Morrison, Alexander Auais, et al.
Seminars in Respiratory and Critical Care Medicine|August 10, 2005
Timing of lung transplantation for patients with fibrotic lung diseasesK R Flaherty, E S White, S E Gay, et al.
Journal of Thoracic Imaging|November 18, 2006
Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolutionAnil K Attili, Ella A Kazerooni, Barry H Gross, et al.
Academic Pediatrics|March 12, 2019
Screening for Access to Firearms by Pediatric Trainees in High-Risk PatientsCaitlin Naureckas Li, Chana A Sacks, Kyle A McGregor, et al.
Immunotherapy Advances|November 29, 2023
Efficacy of PD-1 checkpoint inhibitor therapy in melanoma and beyond: are peripheral T cell phenotypes the key?Katie R Flaherty, Stephanie Kucykowicz, Johannes Schroth, et al.
Pageof 25